Explore how global generic drug policies impact prices and access. From China's bulk buying to US savings, discover the trade-offs between cost, quality, and innovation in international healthcare.
READ MORE
The EMA and FDA approve the same drugs but issue different labels due to distinct legal frameworks, risk approaches, and patient data standards. These differences impact global access, prescribing, and drug development costs.
READ MORE